EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor

Sajjan Rajpoot iD, Tomokazu Ohishi, Ashutosh Kumar, Qiuwei Pan, Sreeparna Banerjee, Kam Y J Zhang, Mirza S Baig

Drugs in R&D · 2021-09 · 21 (3) · 273-283

DOI: 10.1007/s40268-021-00357-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drugs in R&D, online erschienen am 29.07.2021. Verfasst von Sajjan Rajpoot und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Biomedical Engineering (BSBE), Indian Institute of Technology Indore (IITI), Simrol, Indore, 453552, India. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin-Converting Enzyme 2Antiviral AgentsBinding SitesComputer SimulationDrug DesignHumansModels, MolecularMolecular Docking SimulationMolecular Dynamics SimulationMolecular StructurePeptidesProtein BindingSpike Glycoprotein, CoronavirusSubstrate Specificity

Substanzen

Antiviral AgentsPeptidesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2ACE2 protein, humanAngiotensin-Converting Enzyme 2

Autor:innen und Institutionen

  • Department of Biosciences and Biomedical Engineering (BSBE), Indian Institute of Technology Indore (IITI), Simrol, Indore, 453552, India.
  • Institute of Microbial Chemistry (BIKAKEN), Microbial Chemistry Research Foundation, Numazu-shi, Shizuoka, Japan.
  • Laboratory for Structural Bioinformatics, Center for Biosystems Dynamics Research, RIKEN, Tsurumi, Yokohama, Kanagawa, Japan.
  • Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.
  • Department of Biological Sciences, Orta Doğu Teknik Üniversitesi (ODTU/METU), Ankara, Turkey.
  • Department of Biosciences and Biomedical Engineering (BSBE), Indian Institute of Technology Indore (IITI), Simrol, Indore, 453552, India. msb.iit@iiti.ac.in.

ORCID-Profile: Sajjan Rajpoot

Zitieren

APA

Rajpoot, S., Ohishi, T., Kumar, A., Pan, Q., Banerjee, S., Zhang, K. Y. J., & Baig, M. S. (2021). A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor. Drugs in R&D, 21(3), 273-283. https://doi.org/10.1007/s40268-021-00357-0

Vancouver

Rajpoot S, Ohishi T, Kumar A, Pan Q, Banerjee S, Zhang KYJ, et al. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor. Drugs in R&D. 2021;21(3):273-283. doi:10.1007/s40268-021-00357-0

BibTeX
@article{Rajpoot2021,
  author = {Rajpoot, Sajjan and Ohishi, Tomokazu and Kumar, Ashutosh and Pan, Qiuwei and Banerjee, Sreeparna and Zhang, Kam Y J and Baig, Mirza S},
  title = {A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor},
  journal = {Drugs in R&D},
  year = {2021},
  volume = {21},
  number = {3},
  pages = {273--283},
  doi = {10.1007/s40268-021-00357-0}
}
Kostenlos starten →